Skip to main content
Premium Trial:

Request an Annual Quote

Tepnel Plans New Facility in Scotland to Flesh Out PGx Play

NEW YORK, Feb. 23 (GenomeWeb News) - Tepnel Life Sciences today announced it has bought 1.7 acres in Livingston, Scotland to construct a dedicated pharmaceutical, protein, and genomic facility.


The facility will allow the company to expand its pharmacogenomics capabilities to include high-throughput genotyping and other genomic techniques, said Tepnel in a statement.


Tepnel is a UK-based molecular diagnostics company with laboratories in the US, UK, and France.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.